We also showed that in vitro treatment with the JAK2 inhibitor AG490, or the STAT3 inhibitor Stattic was able to trigger time- and dose-dependent apoptosis of CLL cells. The gene discussed is STAT3; the disease is B-cell chronic lymphocytic leukemia.